Potential therapeutic indications for growth hormone and growth hormone-releasing hormone in conditions other than growth retardation.
Growth hormone (GH) previously was available in limited supply and only for the treatment of GH-deficient children. The recent production of GH by recombinant DNA technology has provided a potential surfeit of this hormone and raises the possibility of its use in other conditions. In addition, the isolation, characterization, and synthesis of GH-releasing hormone (GRH) provides an opportunity to use this peptide in conditions in which increased circulating levels of GH are desired. Both GH and GRH have potential therapeutic uses in conditions other than growth retardation.
D000375:Aging / Q000187:drug effects; D000818:Animals; D001851:Bone Diseases, Metabolic / Q000188:drug therapy; D004920:Erythropoiesis / Q000187:drug effects; D006130:Growth Disorders / Q000188:drug therapy; D013006:Growth Hormone / Q000502:physiology / Q000627:therapeutic use*; D013007:Growth Hormone-Releasing Hormone / Q000502:physiology / Q000627:therapeutic use*; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy; D007154:Immune System Diseases / Q000188:drug therapy / Q000503:physiopathology; D007674:Kidney Diseases / Q000188:drug therapy / Q000503:physiopathology; D009765:Obesity / Q000188:drug therapy / Q000503:physiopathology; D011488:Protein Deficiency / Q000188:drug therapy
D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone